Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 1

Interventions

Nivolumab 22pembrolizumab 20Ipilimumab 16Specimen Handling 15Magnetic Resonance Spectroscopy 9CTLA-4 Antigen 8Opdualag 6Cyclophosphamide 6relatlimab 5binimetinib 5trametinib 4fludarabine phosphate 4fludarabine 4Paclitaxel 4Biopsy 4dabrafenib 3cemiplimab 3atezolizumab 3X-Rays 3Standard of Care 3Introns 3Interferon alpha-2 3Immunoglobulin G 3Gemcitabine 3Disulfides 3Carboplatin 3Blood Specimen Collection 3ulixertinib 2sargramostim 2lifileucel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
CBLC137 × Dermatologic × 30 days × Clear all
NCT05498792 2026-05-22

Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma

Fox Chase Cancer Center

Phase EARLY_PHASE1 Recruiting
12 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡